chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: During a mass flu clinic for adults and children I gave a child Fluarix, meant for adults 18 years old and older, by mistake.  No known adverse events.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: During a mass flu clinic for adults and children, a child received Fluarix, meant for adults 18 years old and older, by mistake.  No known adverse events. No adverse event occured.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: Shortness of breath, asthma like exacerbation.  Fever 102.1.
Age: 0.95
Sex: F
Vaccine: DTAPH, FLUX, VARCEL
Symptoms: Erythema, Injection site infection, Injection site rash
Clinical narrative: 5-6 days out had erythema around site with 1-2 very small 3 mm pustules.  ??secondary infection.
Age: 10.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: During mass flu clinic for adults and children, a child under 18 years received 1 dose of "FLUARIX" meant for adults 18 years and above in error. No known adverse events. Follow-up - No adverse event occurred.
Age: 46.0
Sex: F
Vaccine: FLU3, HEPAB
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pruritus, Rash
Clinical narrative: Received Influenza vaccine 11/15/05. Reports that next day 11/16/06, redness, swelling and burning pain at site of injection and "itchy rash" on abdomen, scalp times 3 days. Saw PCP on 11/17/06 who RX antihistamine and Ibuprofen. No redness or swelling observed on 11/20/06. Subjection reports of decreased pain by 11/27/06.
Age: 1.34
Sex: F
Vaccine: DTAP, FLU3, HIBV, PNC
Symptoms: Pyrexia
Clinical narrative: High fever to 103-104 degrees within 12 hours of vaccine
Age: 14.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Cerebrovascular accident, Convulsion
Clinical narrative: Grandmother calls HD states above client had 2 seizures or "possible stroke" today prior to call to HD at 11:55 am. Has not taken client in for care. Encouraged to call client's doctor for treatment at time of immunization gm (custodian) denied allergies or any problems with immunizations today client question may have had a problem with pertussis immunization. GM states this did not reveal at immunization time 11/20/06. GM states client recovered.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: Left upper arm hot, erythematous swollen (22 cm right arm) 24.5 cm swelling 7x8cm erythema
Age: 7.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: During a mass Flu Clinic for adults and children, I gave "FLUARIX" to a child meant for adults 18 years and older by mistake. No known adverse events.  Follow-up - No adverse events occurred.
Age: 7.0
Sex: F
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: During mass Flu Clinic for adults and children I gave "Fluarix" to a child, meant for adults 18 years and older by mistake. No known adverse events.  No adverse events occurred.
Age: 12.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: During mass Flu Clinic for adults and children I gave "FLUARIX" to a child, meant for adults 18 years and older by mistake. No known adverse events.  Follow-up - No adverse events occurred.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: During mass Flu Clinic for adults and children I gave "Fluarix" to a child, meant for adults 18 years and older by mistake. No known adverse events.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: Vaccine administrator gave "FLUARIX" to a child by mistake that is meant for adults 18 year old and older.  No known adverse events.  Follow-up - No adverse events occurred.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: A vaccine administrator gave "Fluarix" to a child meant for adults 18 years and older by mistake. No known adverse events. No adverse event occured.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Dysphonia, Fatigue
Clinical narrative: Hoarseness, fatigue. Treatment-Vicks over counter cough medicine for 2 weeks, gargled with salt water.
Age: 9.0
Sex: F
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: During a mass flu clinic for adults and children, a child received "FLUARIX" meant for 18 year old and older by mistake. No known adverse events.  Follow-up - No adverse events occurred.
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Wrong drug administered
Clinical narrative: A vaccine administrator during a flu clinic for adults and children. A child under 18 years old received 1 dose of "Fluarix" meant for adults 18 and older in error.  No known adverse events.  No adverse event occured.  3-28-07.
Age: 47.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Rash
Clinical narrative: Rash all over body
Age: 0.17
Sex: M
Vaccine: RV5
Symptoms: Pyrexia, Vomiting
Clinical narrative: Information has been received from a physician concerning a 2-month-old male who on 31-OCT-2006 was vaccinated with a 2 mL oral dose of ROTATEQ. Approximately 24 hours after receiving the vaccine, on 31-OCT-2006, the patient experienced vomiting and had a fever of 101.8. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 0.21
Sex: U
Vaccine: RV5
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning an 11 week old who was vaccinated with a dose of ROTATEQ. About three weeks later the patient experienced a fever. Additional information has been requested.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Rash
Clinical narrative: Generalized rash on shoulder and chest/face.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot
Clinical narrative: After injection childs arm turned red and hot.
Age: 1.04
Sex: M
Vaccine: DTAP, HIBV, MMR, OPV
Symptoms: Nonspecific reaction
Clinical narrative: Symptoms appeared on face 11/30/06. 12/01/06 spread to trunk and all extremities.
Age: 1.61
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Erythema, Feeling hot, Injection site reaction, Swelling
Clinical narrative: Approx 6cmx8cm reddened area of L thigh. Injection site- warm to touch, redness/swelling has increased over last 2 days. Redness started 11/30/06 a couple hours after injection. No hardness or lump noted. Instructed to apply warm pack every 10 hours and monitor for redness or hardening or pain. Return to clinic if any question. Probable local reaction.
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Dyspnoea, Pyrexia, Urticaria
Clinical narrative: 20 minutes after vaccine. Developed red rosy cheeks, progressed to hives, urticaria that is worsening today. Now is febrile and having some difficulty with breathing.
Age: 65.0
Sex: F
Vaccine: PPV, UNK
Symptoms: Dyspnoea, Erythema, Pain, Swelling
Clinical narrative: Arm swelled up, pain, redness, hard time breathing.
Age: 65.0
Sex: F
Vaccine: PPV, UNK
Symptoms: Erythema, Feeling hot, Oedema
Clinical narrative: Arm swelled up, pain, redness, hard time breathing.
Age: 31.0
Sex: F
Vaccine: HEP
Symptoms: Feeling hot, Myalgia, Swelling
Clinical narrative: Patient said about 8:00pm her arm started swelling and was sore. Today at 12:10 patient arm is swollen, slightly tight feeling and warm to touch. Instructed patient to apply cold compresses to site.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: Erythema with swelling. Left arm 4 cm erythema.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Headache, Irritability, Lethargy
Clinical narrative: Mom called 11/28 to report that patient had reaction 11/13/06 after receiving MMR. She had headache, irritability and lethargy. Mom gave her a hameopathic remedy which seemed to help lethargy. Irritability gradually has subsided.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Urticaria
Clinical narrative: Developed hives on leg an buttocks evening after shot. 18 hours later.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Feeling hot
Clinical narrative: Patient received vaccine 12/4/06-noted in evening site warm to touch with redden lines. Seen in office at 0930 12/5/06. Treated with Penicillin, warm compresses follow up appointment 12/6/06.
Age: 0.31
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Cough, Nasopharyngitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 33 day old white male with no known drug allergies, and a history of maternal vaccine exposure, vaginal delivery, and an umbilical cord around neck, and a who had a family history of great grandfathers and grandfathers who had diabetes, cancer, epilepsy or seizures, asthma, high blood pressure, and stroke, who was vaccinated with a first, second, and third dose in the right thigh of hepatitis B virus vaccine on 04 Nov 2004 (Lot#649287/0410P), 27-Dec-2004 (Lot # 649286/0807P), and 05-Sep-2005 (Lot# 652221/0545R), respectively. Concomitant vaccines included a first, second, third, and fourth dose in the right thigh of Prevnar on 04-Nov-2004 (Lot # A67180B), 27-Dec-2004 (Lot# A57861K), 08-Mar-2005, and 05-Sep-2005 (Lot#A98339K), respectively, a first, second, and third dose in the left thigh of Tripedia on 04-Nov-2004 (Lot# X0P00), 27-Dec-2004 (Lot# X12121), and 08-Mar-2005, respectively. During a 6 month check up on 08-Mar-2005, the physician noted that the patient was breast feeding well and starting cereal. Initiation of solids was discussed. Normal void and stool was reported. Normal stooling variants were discussed. One or two night feeding was reported. Normal sleep variants were discussed. There were no concerns about hearing or vision. Working and reaching for toys, cooing and babbling, turning to voice, and rolling over were reported. The patient was awake and alert. The anterior fontanelle was open, soft, flat. Red reflex was present bilaterally. Tympanic membranes were normal bilaterally. Oropharynx was clear without erythema or exudates. Moist oral mucosa without lesions was reported. Heart had regular rate and rhythm without murmurs. Lungs were clear to auscultation bilaterally. Abdomen was soft, nontender, nondistended with normal bowel sounds and with no hepatosplenomegaly or palpable masses. Genitalia was normal. Femoral pulse was palpable. There were no hip clunks. There was full abduction bilaterally. There were symmetric skin folds on thighs. The patient moved all extremities well. There was good muscle tone and head control. Moderate pectus excavatum was noted. It was reported that the patient had cold symptoms, a low grade temperature according to the patient's mother, and a cough. The patient was treated with ibuprofen (Motrin), Augmentin ES, and Vigamox. The assessment was a well six month old with pectus excavatum. The plan was for routine health maintenance, anticipatory guidance, reassurance, expectant management, and to follow-up with nine month well child check up. The patient's vaccination history includes a first dose on the left thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot # 547107/0484R) on 06-Sep-2005, and a first dose in the left thigh of varicella virus vaccine live (Lot# 646666/0066R) on 06-Sep-2005. The patient previously experienced pectus excavatum following exposure to varicella virus vaccine live (WAES# 0401USA01755). Additional information has been requested.
Age: 0.33
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Nasal congestion
Clinical narrative: Information has been received from a physician concerning a 9 month old male with no known allergies, a history of hydrocele and whose mother was vaccinated with varicella virus vaccine live (WAES#0405USA00395) while pregnant who was vaccinated in the left thigh with a first and second dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine on 21-Jan-2005 (lot# 649690/0568P) and on 01-Apr-2005 (lot #649691/1014P). Concomitant vaccination that day included a second dose of Daptacel (lot #C2000AA) in the right thigh, a second dose of Ipol (lot# Y0240) in the right thigh and  second dose of Prevnar (lot # A671841L) in the left thigh. On 09-Sep-2005 the patient was seen for his 9 month well child care visit. At this time the patient presented with congestion. It was noted that a CBC was to be performed, results not reported. The patient's outcome was unknown. The patient's vaccination history included: a first and third dose of Daptacel on  21-Jan 2005 (lot # C21262AA) in the right thigh and on 10 Jun 2005 (lot# X1244) in the right thigh and on 10-Jun 2005 (lot# Yo264) in the lower left thigh, and a first and third dose of Prevnar on 21-Jan-2005 (lot# A67181H) and on 10-Jun-2005 (lot# A94440H) in the right thigh. Additional information has been requested.
Age: 0.5
Sex: M
Vaccine: HBHEPB
Symptoms: Hypoglobulinaemia, Laboratory test abnormal
Clinical narrative: Information has been received from a consumer concerning her son who was vaccinated intramuscularly at 2 months and 4 months with a first and second dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC). At 6 months of age, in 2004, the patient was diagnosed with transient hypogammaglobulinemia. The vaccination series along with all other vaccinations series were discontinued. At the time of this report, her son was two and a half years old and had made progress with the amount of IgG and IgA. However, they were still not at normal levels. A physician was recommending that the patient continue the series of vaccinations. The patient's mother reported that neither she nor the physician associated the patient's condition as a result of vaccination. No further information is available.
Age: 2.5
Sex: M
Vaccine: HBHEPB
Symptoms: Incorrect dose administered, Neurodevelopmental disorder
Clinical narrative: Information has been received from the mother of a 30 month old male with no other pertinent medical history and no known allergies or adverse drug reactions reported who "at two months of age" was vaccinated SC with hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (date unknown). Concomitant therapy included unspecified antibiotics. At 30 months of age, the patient was reported to have experienced some "developmental delays"(date unknown). The patient sought unspecified medical attention. The patient underwent an Individualized Education Plan (IEP) Evaluation (results not reported). At the time of this report, the patient had not recovered from the event.  In follow up it was reported from an office worker that the patient had not been seen by the physician since 2004. In follow up information received on 26 Jul 2006 it was reported from an office  worker that the patient was no longer a patient of the physician's office and that the patient had transferred to another physician taking his records with him. The office had no details pertaining to this patient any longer and could not provide any information regarding the adverse event reported. No further information is available.
Age: 2.0
Sex: M
Vaccine: HBHEPB
Symptoms: Application site reaction, Feeling hot, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Information has been received from a certified medical assistant concerning a 26 month old male infant, who on 11 Aug 2006 was vaccinated intramuscularly into the right thigh with a second 0.5mL dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (Lot #653774/0010F). The next morning, on 12 Aug 2006, the patient experienced a reaction. The size of his reaction was 8 by 8cm and had the red, warm, painful, and induration at the site of the injection. The physician advised the mother to use over the counter antihistamine. The patient had one past hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) vaccination and had no reaction. The patient's clinical outcome was reported as recovering. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: HBHEPB
Symptoms: Feeling hot, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Information has been received from a certified medical assistant concerning a 4 year old male with no allergies, who on 11-Aug-2006 was vaccinated IM into the right thigh with a third 0.5ml dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (lot# 653774/0010F). On the morning of 12 Aug 2006, the patient experienced a 14 by 16 cm red, warm, raised, painful, induration at site of the injeciton. It was noted that the patient was not in any respiratory distress. The patient was treated with over the counter antihistamines. No diagnostic laboratory studies were performed. At the time of this report, the patient was recovering. No product  quality complaint was involved. Additional information has been requested.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: itching, redness, swelling more than 1 week. Used antihistamines.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: erythema 15cm x 10cm, itcym red, warm to touch.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Back pain, Chills, Depression, Dizziness, Dyspnoea
Clinical narrative: Two days after shot I started to feel terrible with difficult breathing, wheezing, paleness, weakness, ears plugged bad, dizzines, depression, light fever, chills, cold sweating, back pains,light skin irritation, nose congestion.  Today 12/05/06 after more than 4 weeks and three medical visits I still have some of the symptoms described.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Ear discomfort, Hyperhidrosis, Malaise, Nasal congestion, Pallor
Clinical narrative: Two days after shot I started to feel terrible with difficult breathing, wheezing, paleness, weakness, ears plugged bad, dizzines, depression, light fever, chills, cold sweating, back pains,light skin irritation, nose congestion.  Today 12/05/06 after more than 4 weeks and three medical visits I still have some of the symptoms described.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Skin irritation, Wheezing
Clinical narrative: Two days after shot I started to feel terrible with difficult breathing, wheezing, paleness, weakness, ears plugged bad, dizzines, depression, light fever, chills, cold sweating, back pains,light skin irritation, nose congestion.  Today 12/05/06 after more than 4 weeks and three medical visits I still have some of the symptoms described.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Feeling hot
Clinical narrative: erythema 1.5" x 1.0", redened, warm to touch. Used ice & Ibuprofen.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: redness, warm to touch, swelling.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Angina pectoris, Blood pressure increased, Chest pain, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: Chest pain, SOB, nausea, abnormal EKG and elevated blood pressure within 48 hours of shot.  Pain decreased with nitro. Transported to ER by ambulance admitted for 3 days heart cath performed and within normal range and normal cardic enzymes within first 48 hours of chest pain. 12/22/06-records received and reviewed. Cardiac consultation Impression: angina symptoms Hypertension.  Seen in ER with C/O dizziness, sudden onset of chest pain. Echocardiogram: normal left ventricular systolic function with an estimated ejection fraction of 55 to 60% without any evidence of left ventricular hypertrophy, dilatation or regional wall motion abnormalities. Cardiac angiography: no coronary stenosis, no coronary anomaly, no bridging coronary arteries, normal left ventricular systolic function, normal left ventricular end diastolic pressure at 10mmHg.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Hypertension, Nausea, Urine analysis abnormal
Clinical narrative: Chest pain, SOB, nausea, abnormal EKG and elevated blood pressure within 48 hours of shot.  Pain decreased with nitro. Transported to ER by ambulance admitted for 3 days heart cath performed and within normal range and normal cardic enzymes within first 48 hours of chest pain. 12/22/06-records received and reviewed. Cardiac consultation Impression: angina symptoms Hypertension.  Seen in ER with C/O dizziness, sudden onset of chest pain. Echocardiogram: normal left ventricular systolic function with an estimated ejection fraction of 55 to 60% without any evidence of left ventricular hypertrophy, dilatation or regional wall motion abnormalities. Cardiac angiography: no coronary stenosis, no coronary anomaly, no bridging coronary arteries, normal left ventricular systolic function, normal left ventricular end diastolic pressure at 10mmHg.
Age: 57.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain
Clinical narrative: "Pain throughout arm, mostly on top, sometimes a burning sensation, like nerves.  Needed to take tylenol with codeine. Complains wasn't given correctly.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: Complained of "itchy" on stomach, arms, legs with "rash".  Denies swelling, SOB.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Immediate redness and swelling at the injection site.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site mass
Clinical narrative: Lump at injection site immediately following injection.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Woke up morning after receiving flu shot with hives on face, chest, neck arms.  Denies SOB.  Hives were "itchy".
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, VARCEL
Symptoms: Blister, Erythema, Swelling
Clinical narrative: The day after administration of vaccine, had a swollen red right arm with some blisters. Started on Benadryl, warm compresses and Augmentin. Next day the swelling had reduced significantly. Augmentin was stopped.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Bursitis, Hypokinesia, Pain, Sleep disorder
Clinical narrative: Arm "sore".  Feels like "bursitis".  Pain with overhead lifting; keeps him up at night.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Pruritus, Rash, Rash macular, Urticaria
Clinical narrative: pt returned to clinic about 2hrs after vaccination with complaint of pruritis and rash on face, trunk & arms. Pt devloped erethematous macular rash & discrete wheals on face, chest, back, abdomen and upper extremeties & wheals on lower extremities.  Pt received 50mg Diphenhydramine IM and was sent home with diphenhydramine 25-50mg po q6h prn.
Age: 69.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain
Clinical narrative: Pain radiating down left arm.
Age: 0.51
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PPV
Symptoms: Unevaluable event
Clinical narrative: None reported
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Decreased appetite, Fatigue, Headache, Nausea
Clinical narrative: I took the vaccination on Monday 11/28/06. I experience a week of nausea, unusual fatigue, and headaches.  By the end of week I was so nauseated that couldn't really eat.  I didn't take any medicine. By the weekend, I started feeling better.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC
Symptoms: Medication error, Pyrexia
Clinical narrative: Grandmother called HD and said Dr. said 6 month old shouldn't get flu vaccine That it made baby very sick and they were taking baby to Dr. the next day. Regular immunizations and flu were given 11/21/2006. Baby was taken to doctor 6 days later 11/28/2006. Upon talking to baby's mother on 11/29/2006, she stated the baby ran temp 100.4 on the day after the shots.  States doctor gave cough and cold medication.
Age: 16.0
Sex: M
Vaccine: TDAP, TTOX
Symptoms: Arthralgia, Joint swelling, Systemic lupus erythematosus
Clinical narrative: My son's joints, all his joints swelled up the very day following his immunization. His ankles, knees, wrists, elbows were all very swollen and very painful.  He could hardly move.  He has had trouble with his joints ever since.  Dr. was not wanting to see him and prescribed Benadryl.  I insisted he see my son. My son never had any problem with his joints until the got the immunization.  I know he got a combination Diptheria Pertussis and Tetanus shot when I only needed the Tetanus shot for his high school requirement.  I am not exatly sure since the nurse that administered the shot has been let go from the doctor's practice and the medical records I have been given are not detailed.  I would like to sue this doctor for his negligence in not being willing to follow up, especially in light of the severity and quick onset of his symptoms.
Age: 31.0
Sex: M
Vaccine: FLU3, TDAP, VARCEL
Symptoms: Fatigue, Pyrexia, Rash maculo-papular
Clinical narrative: Fever and fatigue 2 weeks post vaccination, noticed maculopapular lesions on trunk, face and arms over several days.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Arthritis, Headache, Memory impairment, Myalgia, Pain
Clinical narrative: Ongoing sero negative spodyloarthritis. Daily Headaches, problems with memory, muscle pain. Currently take multiple morphine, percocet, ultram, indocin, daily to treat pain as well as methotrexate. All conditions started slowly after administration of anthrax shots starting in 02 and ending in 04. Currently going through medical board to retire me from military. 03/07/07-records received. PMH:hypermobility, involved in number of traffic accidents. Widespread musculoskeltal pain. Chronic back pain with chiropractic treatment over several years DX:Spondylitis. Signs and symptoms of mild synovitis do suggest a low grade sero negative arthropathy.  Sacroiliac joints normal. C/O pain in neck, back and hands and toes and fatigability. Per 60 day follow up: Currently diagnosed with seronegative spondyloarthritis & fibromyalgia.
Age: 39.0
Sex: M
Vaccine: HEP
Symptoms: Headache, Neck pain, Shoulder pain
Clinical narrative: severe headache, onset 1/2 hour after vaccine. pain described as 9.9 of 10 on a scale of 1-10. Headache, neck ache, shoulder ache most severe during the first 24 hours, pain continued > 48 hours. Headache & all other pain gone by 55 hours post vaccination. Patient did not notice redness or swelling at the immunization site.
Age: 0.55
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC
Symptoms: Injection site nodule
Clinical narrative: Noticed two nodules swelling around Nov 15th on Right thigh. Slowly came to surface. No complaint of fever, pain, redness. No notice of decreased movement on extremities or any pus.
Age: 0.22
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, RV5
Symptoms: Pyrexia
Clinical narrative: Patient developed high fever after vaccination with Pediarix/Hib/Prevnar/Rotavirus at 2 month. Mom reports 106 axillary at home, 102 in emergency department with blood work, Lipid Panel attempt, antipyretics, no antibiotics.
Age: 4.0
Sex: F
Vaccine: FLUN3
Symptoms: Erythema, Myalgia, Oedema peripheral, Pain, Pain in extremity
Clinical narrative: 2 days after receiving intranasal FluMist vaccine developed pain in hand/feet, general myalgias, itching of skin with rash, mild swelling of the real symptom with erythema.
Age: 4.0
Sex: F
Vaccine: FLUN3
Symptoms: Rash, Skin irritation, Swelling
Clinical narrative: 2 days after receiving intranasal FluMist vaccine developed pain in hand/feet, general myalgias, itching of skin with rash, mild swelling of the real symptom with erythema.
Age: 61.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: 2 days after injection left arm swelled, was red and hot 3 1/2 by 4" long by next day, Dec 1 redness had progressed to whole upper arm, shoulder to elbow and hot and painful.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Pyrexia
Clinical narrative: Erythema, swelling and pain in right lateral thigh, low grade temperature as per husband via telephone 12/04/06. Per pts request injection administered in right lateral thigh.
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Pyloric stenosis, Vomiting
Clinical narrative: Initial report received on 22 November 2006 from another manufacturer, report number WAES0611USA03037. The initial reporter to this manufacturer had been the agency mentioned, VAERS#266248.  A 9-week-old male patient, who had constipation at the time of vaccination, had received a first dose, intramuscular injection of ActHIB, lot number X 1265-2 (lot number UE421AA); a first dose, oral administration of Rotateq, manufacturer reported, lot number 07772; a first dose, intramuscular injection of Pediarix, manufacturer reported, lot number AC21B070AA; and a first dose, intramuscular injection of Prevnar, manufacturer reported, lot number B08672C; on 26 October 2006. The following day, the patient developed pyloric stenosis characterized by vomiting and diarrhea and was hospitalized for four days.  A stool analysis was positive for rotavirus, and an ultrasound was positive for pyloric stenosis.  Per the reporter, the patient's adverse event prolonged hospitalization.  Patient outcome was not provided.
Age: 0.19
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, RV5
Symptoms: Sudden infant death syndrome
Clinical narrative: Initial report received on 22 November 2006, from another manufacturer, report number WAES 0611USA02595, who received the original report from a physician.  A 10 week old female, with no medical history and no allergies, received on 20 October 2006, the first dose in the left thigh of ActHib, (lot#Z0556-2 which corresponds to lot#UE932AA). At 10:45 am, the patient was vaccinated with 2ml oral first dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine) (Rotateq, lot #654248/0577F).  The patient also received the first intramuscular dose in the right thigh of diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (+) tetanus toxoid (Pediarix, lot#AC21B070AA).  On 02 October 2006, the patient was given the first intramuscular dose in the left thigh of pneumococcal 4 6B 9V L4 18C 19F 23F conj vaccine (CRM197) (Prevnar, lot#B086918).  There was no illness at the time of vaccination. On the next day the patient died. The physician stated that the infant received all of her vaccines on time and was in perfect health. The medical examiner ruled the cause of death as sudden infant death syndrome.  Unspecified medical attention was sought.  No product quality complaint was involved.  No further information was provided at the time of the first report (15 November 2006). Follow up information indicated that on the night of 21 October 2006, the patient died of sudden infant death syndrome.  The reporter considered the patient's reaction to be immediately life threatening. A lot check and additional information had been requested by the reporting manufacturer.
Age: 2.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Balance disorder, Blindness, Blood potassium increased, Blood test, Blood urea nitrogen/creatinine ratio increased
Clinical narrative: Sudden onset left eye esotropia 4 days after Fluzone vaccine.
Age: 2.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Coordination abnormal, Haematocrit normal, Haemoglobin normal, Haemolysis, Headache
Clinical narrative: Sudden onset left eye esotropia 4 days after Fluzone vaccine.
Age: 2.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Intracranial pressure increased, Lumbar puncture, Neutrophil count increased, Nuclear magnetic resonance imaging, Ophthalmoplegia
Clinical narrative: Sudden onset left eye esotropia 4 days after Fluzone vaccine.
Age: 2.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Strabismus, Surgery, Visual impairment, White blood cell count normal
Clinical narrative: Sudden onset left eye esotropia 4 days after Fluzone vaccine.
Age: 2.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Strabismus
Clinical narrative: Sudden onset left eye esotropia 4 days after Fluzone vaccine.
Age: 52.0
Sex: F
Vaccine: HEP, UNK
Symptoms: Back pain, Pain, Sleep disorder
Clinical narrative: Pain in arms, neck, back, all large joints (shoulders, elbow, wrists, knees, ankles)
Age: 52.0
Sex: F
Vaccine: HEP, UNK
Symptoms: Arthralgia, Pain, Respiratory failure
Clinical narrative: Pain in arms, neck, back, all large joints (shoulders, elbow, wrists, knees, ankles)
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Atrial fibrillation, Condition aggravated, Ventricular fibrillation
Clinical narrative: A 53 year old male pt, with a history of previous atrial fibrillation, cardioversion, and depression, had received an injection of Fluzone SV 2006-2007, lot number unk, on 11/30/06. Route and site of administration were not reported.  Within one minute post vaccination, the pt went into ventricular fibrillation arrest. He was subsequently shocked times two. The pt was hospitalized and is now in atrial fibrillation. Illness at the time of vaccination was unk. Concomitant medications included daily aspirin and fish oil. Wellbutrin was discontinued. At the time of this report, the pt had not recovered.
Age: 89.0
Sex: M
Vaccine: FLUX
Symptoms: Abasia, Asthenia, CSF test abnormal, Demyelination, Gait disturbance
Clinical narrative: Seriousness criteria other medically significant (OMIC). From initial information received on 1/21/06 from a literature report. a report of three cases, it was reported that three pts were evaluated at the neuromuscular clinic from 2001 to 2005, All pts underwent detailed history, general and neurological examinations, electro diagnostic and lab studies, including spinal fluid, complete blood count, metabolic panel, serology for autoimmune disorders, Lyme serology, VDRL, serum immune fixation, thyroid studies glucose and HBA1C, and MRI for brain and spine. The other two pts from this literature report are reported in cases 200603299 and 200603300. A healthy 89 year old man had received a dose of Influenza vaccine sometime in 2001 to 2005. The date of vaccination was not specified. The trade name, manufacturer, lot number, route and site of administration were not reported. The pt did not have any acute illness or systemic infections prior to the vaccination. He did not have any history of diabetes mellitus, alcohol abuse, exposure to any known neurotoxins, and there was no family history of neuropathy. The pt developed tingling in the hands two days post immunization, followed by progressive weakness, which progressed over two weeks, in his arms and legs. CSF showed 127.3. The pt improved after a05 day course of IVIG over 4 weeks, a month later, the pt experienced more gradual worsening of weakness over 6 weeks, the pt was unable to walk or stand, even with support. Examination showed marked weakness in proximal and distal muscles of all extremities, with absent muscle stretch reflexes. Vibration and diminished in the toes, and other sensations were intact. Electro diagnostic studied showed widespread abnormalities, indication a demyelinating polyneuropathy. Needle EMG showed fibrillation potentials, and loss of motor unit potentials, in the distal upper and lower extremity muscles. Pt was treated with monthly IVIG 1g/kg monthly) and oral mycophenolate 1000 mg bid. IVIG was discontinued after 6 months, at the 16 month follow up, the pt showed normal gait and only mild weakness of intrinsic hand muscle (grade 4 MRC). Pts status at the last follow up indicated that he was ambulating with a cane, and had mild weakness in his arms. The authors conclusion is that this pt , who was other wise health, developed CIDP with rapid onset in close proximity to influenza vaccinations, suggesting a plausible relationship between the immunization and the induction of CIDP. It is possible that antecedent events such as immunization are more likely in such pts,  but has not been systemically evaluated. In contrast to GBS, which is a monophasic illness, how a single event such as immunization may trigger induction of a relapsing or chronic immune mediated disorder such as CIDP is not known. The reporter for this case is the same as for cases 200603300 and 200603298.
Age: 89.0
Sex: M
Vaccine: FLUX
Symptoms: Hypokinesia, Hyporeflexia, Laboratory test abnormal, Muscular weakness, Paraesthesia
Clinical narrative: Seriousness criteria other medically significant (OMIC). From initial information received on 1/21/06 from a literature report. a report of three cases, it was reported that three pts were evaluated at the neuromuscular clinic from 2001 to 2005, All pts underwent detailed history, general and neurological examinations, electro diagnostic and lab studies, including spinal fluid, complete blood count, metabolic panel, serology for autoimmune disorders, Lyme serology, VDRL, serum immune fixation, thyroid studies glucose and HBA1C, and MRI for brain and spine. The other two pts from this literature report are reported in cases 200603299 and 200603300. A healthy 89 year old man had received a dose of Influenza vaccine sometime in 2001 to 2005. The date of vaccination was not specified. The trade name, manufacturer, lot number, route and site of administration were not reported. The pt did not have any acute illness or systemic infections prior to the vaccination. He did not have any history of diabetes mellitus, alcohol abuse, exposure to any known neurotoxins, and there was no family history of neuropathy. The pt developed tingling in the hands two days post immunization, followed by progressive weakness, which progressed over two weeks, in his arms and legs. CSF showed 127.3. The pt improved after a05 day course of IVIG over 4 weeks, a month later, the pt experienced more gradual worsening of weakness over 6 weeks, the pt was unable to walk or stand, even with support. Examination showed marked weakness in proximal and distal muscles of all extremities, with absent muscle stretch reflexes. Vibration and diminished in the toes, and other sensations were intact. Electro diagnostic studied showed widespread abnormalities, indication a demyelinating polyneuropathy. Needle EMG showed fibrillation potentials, and loss of motor unit potentials, in the distal upper and lower extremity muscles. Pt was treated with monthly IVIG 1g/kg monthly) and oral mycophenolate 1000 mg bid. IVIG was discontinued after 6 months, at the 16 month follow up, the pt showed normal gait and only mild weakness of intrinsic hand muscle (grade 4 MRC). Pts status at the last follow up indicated that he was ambulating with a cane, and had mild weakness in his arms. The authors conclusion is that this pt , who was other wise health, developed CIDP with rapid onset in close proximity to influenza vaccinations, suggesting a plausible relationship between the immunization and the induction of CIDP. It is possible that antecedent events such as immunization are more likely in such pts,  but has not been systemically evaluated. In contrast to GBS, which is a monophasic illness, how a single event such as immunization may trigger induction of a relapsing or chronic immune mediated disorder such as CIDP is not known. The reporter for this case is the same as for cases 200603300 and 200603298.
Age: 89.0
Sex: M
Vaccine: FLUX
Symptoms: Polyneuropathy
Clinical narrative: Seriousness criteria other medically significant (OMIC). From initial information received on 1/21/06 from a literature report. a report of three cases, it was reported that three pts were evaluated at the neuromuscular clinic from 2001 to 2005, All pts underwent detailed history, general and neurological examinations, electro diagnostic and lab studies, including spinal fluid, complete blood count, metabolic panel, serology for autoimmune disorders, Lyme serology, VDRL, serum immune fixation, thyroid studies glucose and HBA1C, and MRI for brain and spine. The other two pts from this literature report are reported in cases 200603299 and 200603300. A healthy 89 year old man had received a dose of Influenza vaccine sometime in 2001 to 2005. The date of vaccination was not specified. The trade name, manufacturer, lot number, route and site of administration were not reported. The pt did not have any acute illness or systemic infections prior to the vaccination. He did not have any history of diabetes mellitus, alcohol abuse, exposure to any known neurotoxins, and there was no family history of neuropathy. The pt developed tingling in the hands two days post immunization, followed by progressive weakness, which progressed over two weeks, in his arms and legs. CSF showed 127.3. The pt improved after a05 day course of IVIG over 4 weeks, a month later, the pt experienced more gradual worsening of weakness over 6 weeks, the pt was unable to walk or stand, even with support. Examination showed marked weakness in proximal and distal muscles of all extremities, with absent muscle stretch reflexes. Vibration and diminished in the toes, and other sensations were intact. Electro diagnostic studied showed widespread abnormalities, indication a demyelinating polyneuropathy. Needle EMG showed fibrillation potentials, and loss of motor unit potentials, in the distal upper and lower extremity muscles. Pt was treated with monthly IVIG 1g/kg monthly) and oral mycophenolate 1000 mg bid. IVIG was discontinued after 6 months, at the 16 month follow up, the pt showed normal gait and only mild weakness of intrinsic hand muscle (grade 4 MRC). Pts status at the last follow up indicated that he was ambulating with a cane, and had mild weakness in his arms. The authors conclusion is that this pt , who was other wise health, developed CIDP with rapid onset in close proximity to influenza vaccinations, suggesting a plausible relationship between the immunization and the induction of CIDP. It is possible that antecedent events such as immunization are more likely in such pts,  but has not been systemically evaluated. In contrast to GBS, which is a monophasic illness, how a single event such as immunization may trigger induction of a relapsing or chronic immune mediated disorder such as CIDP is not known. The reporter for this case is the same as for cases 200603300 and 200603298.
Age: 84.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Coordination abnormal, Demyelination, Gait disturbance, Hypoaesthesia
Clinical narrative: Seriousness criteria other medically significant (OMIC). From initial information received on 11/21/06 from a literature report. A report of three cases, it was reported that three pts were evaluated at the neuromuscular clinic from 2001 to 2005, All pts underwent detailed history, general and neurological examinations, electro diagnostic and lab studies, including spinal fluid, complete blood count, metabolic panel, serology for autoimmune disorders, Lyme serology, VDRL, serum immune fixation, thyroid studies glucose and HBA1C, and MRI for brain and spine. The other two pts from this literature report are reported in cases 200603299 and 200603300. A healthy 84 year old female had received a dose of Influenza vaccine sometime in 2001 to 2005. The date of vaccination was not specified. The trade name, manufacturer, lot number, route and site of administration were not reported. The pt did not have any acute illness or systemic infections prior to the vaccination. He did not have any history of diabetes mellitus, alcohol abuse, exposure to any known neurotoxins, and there was no family history of neuropathy. Twenty one days post immunization, the pt experienced severe pain in a band like distribution in the mid thoracic region. Four days later, she experienced progressive weakness and numbness which progressed over 6 weeks, in her legs and hands. She was able to take a few steps with a walker, and she had marked weakness in proximal and distal muscles of upper lower extremities. Muscle stretch reflexes were absent in the legs and diminished in the arms, vibration was absent in the feet, but proprioception and pin sensation were intact. Gait was broad based and ataxic. Her CSF was 136.0. The pt did not improve with a 5 day course of IVIG. She was then treated with weakly oral prednisone starting at 150 mg/wk for 2 months followed by a slow taper to 20 mg/wk, At 14 months follow up, the pt is able to ambulate without assistance, and she has mild weakness (grade 4 MRC) in deltoid, intrinsic hand muscles, and hip flexion. Reflexes remain absent in the lower extremities. The pts status at the last follow up indicated that she could ambulate independently, and had mild weakness in her arms. The authors conclusion is that this pt , who was other wise health, developed CIDP with rapid onset in close proximity to influenza vaccinations, suggesting a plausible relationship between the immunization and the induction of CIDP. It is possible that antecedent events such as immunization are more likely in such pts,  but has not been systemically evaluated. In contrast to GBS, which is a monophasic illness, how a single event such as immunization may trigger induction of a relapsing or chronic immune mediated disorder such as CIDP is not known. The reporter for this case is the same as for cases 200603299, and 200603298.
Age: 84.0
Sex: F
Vaccine: FLUX
Symptoms: Hyporeflexia, Muscular weakness, Pain, Polyneuropathy
Clinical narrative: Seriousness criteria other medically significant (OMIC). From initial information received on 11/21/06 from a literature report. A report of three cases, it was reported that three pts were evaluated at the neuromuscular clinic from 2001 to 2005, All pts underwent detailed history, general and neurological examinations, electro diagnostic and lab studies, including spinal fluid, complete blood count, metabolic panel, serology for autoimmune disorders, Lyme serology, VDRL, serum immune fixation, thyroid studies glucose and HBA1C, and MRI for brain and spine. The other two pts from this literature report are reported in cases 200603299 and 200603300. A healthy 84 year old female had received a dose of Influenza vaccine sometime in 2001 to 2005. The date of vaccination was not specified. The trade name, manufacturer, lot number, route and site of administration were not reported. The pt did not have any acute illness or systemic infections prior to the vaccination. He did not have any history of diabetes mellitus, alcohol abuse, exposure to any known neurotoxins, and there was no family history of neuropathy. Twenty one days post immunization, the pt experienced severe pain in a band like distribution in the mid thoracic region. Four days later, she experienced progressive weakness and numbness which progressed over 6 weeks, in her legs and hands. She was able to take a few steps with a walker, and she had marked weakness in proximal and distal muscles of upper lower extremities. Muscle stretch reflexes were absent in the legs and diminished in the arms, vibration was absent in the feet, but proprioception and pin sensation were intact. Gait was broad based and ataxic. Her CSF was 136.0. The pt did not improve with a 5 day course of IVIG. She was then treated with weakly oral prednisone starting at 150 mg/wk for 2 months followed by a slow taper to 20 mg/wk, At 14 months follow up, the pt is able to ambulate without assistance, and she has mild weakness (grade 4 MRC) in deltoid, intrinsic hand muscles, and hip flexion. Reflexes remain absent in the lower extremities. The pts status at the last follow up indicated that she could ambulate independently, and had mild weakness in her arms. The authors conclusion is that this pt , who was other wise health, developed CIDP with rapid onset in close proximity to influenza vaccinations, suggesting a plausible relationship between the immunization and the induction of CIDP. It is possible that antecedent events such as immunization are more likely in such pts,  but has not been systemically evaluated. In contrast to GBS, which is a monophasic illness, how a single event such as immunization may trigger induction of a relapsing or chronic immune mediated disorder such as CIDP is not known. The reporter for this case is the same as for cases 200603299, and 200603298.